vs
BICYCLE THERAPEUTICS PLC（BCYC）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是BICYCLE THERAPEUTICS PLC的2.0倍（$94.3M vs $48.0M），REPUBLIC BANCORP INC净利率更高（24.2% vs -42.0%，领先66.2%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-19.9M），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs -11.5%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BCYC vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的2.0倍
$48.0M
营收增速更快
BCYC
高出1188.0%
5.3%
净利率更高
RBCAA
高出66.2%
-42.0%
自由现金流更多
RBCAA
多$181.0M
$-19.9M
两年增速更快
BCYC
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $94.3M |
| 净利润 | $-20.2M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | 29.3% |
| 净利率 | -42.0% | 24.2% |
| 营收同比 | 1193.3% | 5.3% |
| 净利润同比 | 61.1% | 20.0% |
| 每股收益（稀释后） | $-0.29 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCRBCAA
| Q4 25 | $48.0M | $94.3M | ||
| Q3 25 | $11.7M | $93.5M | ||
| Q2 25 | $2.9M | $93.8M | ||
| Q1 25 | $10.0M | $135.8M | ||
| Q4 24 | $3.7M | $89.5M | ||
| Q3 24 | $2.7M | $88.1M | ||
| Q2 24 | $9.4M | $86.9M | ||
| Q1 24 | $19.5M | $120.3M |
净利润BCYCRBCAA
| Q4 25 | $-20.2M | $22.8M | ||
| Q3 25 | $-59.1M | $29.7M | ||
| Q2 25 | $-79.0M | $31.5M | ||
| Q1 25 | $-60.8M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-50.8M | $26.5M | ||
| Q2 24 | $-39.8M | $25.2M | ||
| Q1 24 | $-26.6M | $30.6M |
营业利润率BCYCRBCAA
| Q4 25 | -51.5% | 29.3% | ||
| Q3 25 | -558.6% | 40.4% | ||
| Q2 25 | -2965.8% | 43.0% | ||
| Q1 25 | -703.7% | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | -2385.9% | 38.4% | ||
| Q2 24 | -498.3% | 37.0% | ||
| Q1 24 | -162.4% | 32.2% |
净利率BCYCRBCAA
| Q4 25 | -42.0% | 24.2% | ||
| Q3 25 | -503.7% | 31.8% | ||
| Q2 25 | -2703.8% | 33.5% | ||
| Q1 25 | -608.9% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -1898.4% | 30.1% | ||
| Q2 24 | -425.3% | 29.0% | ||
| Q1 24 | -136.0% | 25.4% |
每股收益（稀释后）BCYCRBCAA
| Q4 25 | $-0.29 | — | ||
| Q3 25 | $-0.85 | — | ||
| Q2 25 | $-1.14 | — | ||
| Q1 25 | $-0.88 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.74 | — | ||
| Q2 24 | $-0.77 | — | ||
| Q1 24 | $-0.62 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $1.1B |
| 总资产 | $717.6M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCRBCAA
| Q4 25 | $628.1M | $220.0M | ||
| Q3 25 | $648.3M | $484.2M | ||
| Q2 25 | $721.5M | $484.8M | ||
| Q1 25 | $793.0M | $793.0M | ||
| Q4 24 | $879.5M | $432.2M | ||
| Q3 24 | $890.9M | $530.9M | ||
| Q2 24 | $961.4M | $400.1M | ||
| Q1 24 | $457.0M | $546.4M |
总债务BCYCRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCRBCAA
| Q4 25 | $610.0M | $1.1B | ||
| Q3 25 | $618.5M | $1.1B | ||
| Q2 25 | $668.9M | $1.1B | ||
| Q1 25 | $740.3M | $1.0B | ||
| Q4 24 | $793.1M | $992.0M | ||
| Q3 24 | $831.0M | $979.7M | ||
| Q2 24 | $873.8M | $955.4M | ||
| Q1 24 | $356.0M | $935.6M |
总资产BCYCRBCAA
| Q4 25 | $717.6M | $7.0B | ||
| Q3 25 | $764.0M | $7.0B | ||
| Q2 25 | $832.2M | $7.0B | ||
| Q1 25 | $883.9M | $7.1B | ||
| Q4 24 | $956.9M | $6.8B | ||
| Q3 24 | $996.7M | $6.7B | ||
| Q2 24 | $1.1B | $6.6B | ||
| Q1 24 | $547.1M | $6.9B |
负债/权益比BCYCRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $161.1M |
| 自由现金流率自由现金流/营收 | -41.5% | 170.9% |
| 资本支出强度资本支出/营收 | 1.2% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $288.6M |
8季度趋势，按日历期对齐
经营现金流BCYCRBCAA
| Q4 25 | $-19.3M | $168.2M | ||
| Q3 25 | $-71.2M | $33.3M | ||
| Q2 25 | $-72.8M | $8.4M | ||
| Q1 25 | $-86.4M | $93.2M | ||
| Q4 24 | $-164.7M | $149.0M | ||
| Q3 24 | $-39.8M | $51.3M | ||
| Q2 24 | $-44.6M | $4.0M | ||
| Q1 24 | $-70.9M | $71.2M |
自由现金流BCYCRBCAA
| Q4 25 | $-19.9M | $161.1M | ||
| Q3 25 | $-71.8M | $30.8M | ||
| Q2 25 | $-73.3M | $5.2M | ||
| Q1 25 | $-87.0M | $91.6M | ||
| Q4 24 | $-166.0M | $143.2M | ||
| Q3 24 | $-40.3M | $49.8M | ||
| Q2 24 | $-45.0M | $2.7M | ||
| Q1 24 | $-70.9M | $69.1M |
自由现金流率BCYCRBCAA
| Q4 25 | -41.5% | 170.9% | ||
| Q3 25 | -612.3% | 32.9% | ||
| Q2 25 | -2509.7% | 5.5% | ||
| Q1 25 | -871.7% | 67.4% | ||
| Q4 24 | -4475.7% | 160.0% | ||
| Q3 24 | -1504.7% | 56.5% | ||
| Q2 24 | -481.2% | 3.1% | ||
| Q1 24 | -362.9% | 57.5% |
资本支出强度BCYCRBCAA
| Q4 25 | 1.2% | 7.5% | ||
| Q3 25 | 5.7% | 2.6% | ||
| Q2 25 | 17.1% | 3.5% | ||
| Q1 25 | 6.1% | 1.2% | ||
| Q4 24 | 33.3% | 6.5% | ||
| Q3 24 | 16.3% | 1.7% | ||
| Q2 24 | 4.5% | 1.5% | ||
| Q1 24 | 0.1% | 1.7% |
现金转化率BCYCRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
